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The secretion of a,-microglobulin by primary cultures of rat hepatocytes was found to increase upon the addition of interleukind or leukemia 
inhibitory faclor, two mediators of acute phase response. This stimulatory effect was further enhanced by dexamelhasone. a,-Microglobulin is 
synthesized as a precursor also containing bikunin, and the precursor protein is cleaved shortly before secretion. Our results therefore suggest that 
both a,-microglobulin and bikunin are acute phase reaclants in ral hepatocytes. Furthermore. we found that retinoic acid. previously shown to 
be involved in the regulation of cell differentiation and development, also stimulated cc,-microglobulin synthesis. Only free, uncomplexed Q,- 
microglobulin (28,000 Da) was detected in the hepatocyte media, suggesting that the complex between a,-microglobulin and a,-inhibitor 3. found 
in rat serum, is formed outside the hepatocyte. 
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1. INTRODUCTION 
a,-microglobulin (a,-m) is a low molecular weight 
plasma protein, belonging to the lipocalin family [l-33. 
It is synthesized by hepatocytes as a precursor contain- 
ing also a proteinase inhibitor, recently named bikunin, 
which is identical to the light chain (HI-30) of inter 
a-trypsin inhibitor (ITI) or pre-a-trypsin inhibitor [4-71. 
Cleavage of the precursor occurs intracellularly shortly 
before secretion [&lo]. In plasma, al-m exists in free 
form but also in a complex with the heavy chain of TgA 
in man [l 11, and with a,-inhibitor 3 in rat [12]. 
The plasma levels of al-m in man (approximately 0.03 
mg/ml) has been reported to be unaffected by neoplastic 
diseases and inflammatory conditions [ 131, although 
some contradictory reports exist [14]. For bikunin, an 
inflammation-associated increase in plasma and urine 
has been demonstrated [3,5,15,16], but it has not been 
clear whether this is caused by increased synthesis or 
increased release from higher molecular mass com- 
plexes. To resolve the question whether cc,-mlbikunin 
are positive acute phase reactants, we have studied the 
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synthesis of al-m in primau cultures of rat hepatocytes 
incubated with factors known to induce typical acute 
phase response [l?-191. 
It was shown previously [20] that the levels of fetal 
and adult rat liver al-m-encoding mRNA vary with age. 
The plasma levels of al-m have also been reported to 
vary with age and development [13,21]. This suggests a 
developmental regulation of the expression of the a& 
bikunin gene. Retinoic acid has been shown to be in- 
volved in cell growth and differentiation of embryonic 
and adult cells [22-241, and experiments in this work 
demonstrate an influence of retinoic acid on the hepa- 
tocyte expression of al-m. 
2. MATERIALS AND METHODS 
2. I. Marerids 
Williams E medium and foetal calf serum were purch;iscd from 
Ciibco (Paisley, Scotland); collagenase (type IV), deaamethasone, 
bovine serum albumin and vitamin A acid all-rrcms (retinoicacid) were 
from Sigma Chemical Co. (St. Louis, MO, USA); human recombinant 
interleukin-6 (IL-6) was a Sift of Dr. W. Fiers (Gent, &I&urn) and 
human recombinant leukemia inhibitory factor (LIF) from Dr. H. 
Baumann (Buffalo, NY, USA). Rat rr,-m was prepared from rat serum 
as described [12]. Rabbit anti-rat al-m and gont anti-rabbit immuno- 
globulins were prepared using conditions as described [12,251. Anti- 
bodies against he rat proteins a,-inhibhor-3, z,-macroglobulin, a,- 
cysteine proteinase inhibhor (CPl), and albumin were prepared in 
rabbits 85 describe? [26]. 
2,2, ffepalocyres 
Hepatocytes were isolated under steri!c conditions from liver of 
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adult Wistar rats after perfusion with ccllagcnase and cultured in 
Williams E medium containing 9 mM NaHCO,,, 2 mM glutamine. I 
yM insulin and initially 5% foctal calf serum 1271. Hepatocyte mo- 
nolayers were obtained by pipatting 1 x IOb cells in I,25 ml medium 
into 35 mm dia culture dishes (Flow Laboratories, McLean, VA, 
USA) coated with collagen. 
After overnight incubation at 37°C in airlCOz (19:l). the unattached 
cells were aspirated and I ml of serum-free medium containing 0.2% 
bovine serum albumin added. This medium was changed after 4 II, and 
0.25 ml of suitable dilutions of IL-6, LIF or rutinoic acid was added. 
Control cultures received 0.25 ml of the medium alone, The media 
were changed daily with appropriate supplementation f the tested 
factors. Media collected after 24 or 48 h of culture were dialyzed 
against 15 mM NH,HCO> and concentrated IO times. 
2.3. E~~crroifruttlrllous~u~J frrttl ra ioi,rl,lllrrtonssq)l 
The concentrations of the five proteins a,-m, al-inhibitor 3, a,- 
macroglobulin, CPl and albumin in the concentrated media were 
estimated by electroimmunoassay using monospecific antisera to rat 
proteins [27]. The concentrations ofal-m in gel chromatography frac- 
tions were determined by radioimmunoassay [28]. Proteins were la- 
belled with lz51 (Nordion Inl. Co., Canada) using chloramine T [29] 
to a specific activity around 0.2 MBq/gg, 
2.4. Gai clwottwogrqdy 
Concentrated hepatocyte culture medium was applied to a column 
(1.2 x 90 cm) packed with Sephadex G-200 (Kabi-Pharmacia, 
Sweden). The column was eluted with 20 mM Tris-HCI, pH 8.0, 
containing 0. IS M NuCl and 0.02% NaN,, at a flow-rate of I .5 ml/h. 
Fractions of 0.75 ml were collected and analyzed by determination of 
the absorbance at 280 nm, and by radioimmunoassay. 
Concentrated hepatocytc culture media were separated by sodium 
dodecyl sulfate-polyacrylamide g l clectrophorcsis (SDS-PAGE) 
under reducing conditions [30]. The separated proteins were then 
either stained with Coomassic brilliant blue or transferred to nitrocel- 
lulose membranes (Bio-Rad. Palo Alto, CA) [31]. The membranes 
were blocked, incubated with anti-rat q-m overnight and ‘?-labclld 
goat-anti-rabbit mmunoglobulins for one hour, washed, dried and 
autoradiographed asdescribed [32]. 
3. RESULTS 
In agreement. with earlier findings [19], we observed 
that rat hepatocytes cultured in the presence of LIF (500 
units/ml) or IL-6 (50 ng/ml) synthesize more of the 
positive acute phase proteins CPI and al-macroglo- 
bulin, especially in the presence of 1 ,uM dexamethasone 
(Table I). Under the same conditions, the synthesis of 
two negative acute phase proteins, q-inhibitor 3 and 
albumin, was suppressed. The synthesis of a,-m showed 
the same pattern of stimulation as CPI and a2-macro- 
globulin. 
The effect of the addition of l.OpM retinoic acid, in 
the presence or absence of dexamethasone, was also 
studied. The synthesis of a,-m, CPI and q-inhibitor 3 
was found to be stimulated by this factor (Table I). 
Contrary to ii-6, the stimuiation was reduced by tile 
presence of dexamethasone. The synthesis of a?-macro- 
globulin and albumin was not significantly affected by 
retinoic acid. A positive dose-response was achieved 
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Table I 
ElXc!s of LlF (500 units/ml), IL-B (SO @ml) and retinoic acid (I PM) 
on the synthesis of CPI. a>-macroglobubn (al-M). a,-inhibitor-3 (a,- 
I,), albumin and q-m by cultured rat hepdtocytcs 
CPI a,-M a,-13 Albumin a,-m 
Culture De% De% Dex DC% Dcx 
(-) (+) (-) (+) (-) (+) (-) (+) (-) (+) 
Control 100 100 100 100 100 LOO 100 LOO LOO 100 
LIF 132 142 I43 240 87 91 92 94 135 159 
11-6 I45 206 228 383 75 82 93 89 154 20s 
Retinoic i42 I21 105 I20 176 II4 99 94 155 140 
acid 
Cells were cultured for 48 h in the medium without (-) or with (+) I 
PM dexamcthasonc. The results arc expressed as percent of control 
culture and are the means of at least 2 cxperimeuts. 
with 0.1, I .O and 10 ,uM retinoic acid on the synthesis 
of al-m and a,-inhibitor 3 (Fig. I). 
The size and molecular distribution of a,-m secreted 
into the medium by the cultured hepatocytes was 
analyzed by gel chromatography of the IL-Gcontaining 
medium after dialysis and concentration (Fig. 2). 
Proteins of various sizes were present as evident from 
the total protein profile of the eluate. The major peak, 
which was eluted at the same position as bovine serum 
albumin, probably corresponds to rat serum albumin, 
Analysis of a,-m in the fractions by radioimmunoassay 
showed that this protein was mainly cluted in a position 
expected from monomeric al-m. This major peak was 
immediately preceded by a shoulder in the a,-m-con- 
tents, however, suggesting the presence of other forms 
of the protein. 
12 3 4 12 3 4 
Fig, I. Electroimmunoassay of &r-m (A) and a,-inhibitor-3 (Et) in the 
media of rat hepetocytes cul!cred for 2 days with medium alone (well 
I), with 0.1 PM retinoic acid (2). I PM retinoic acid (3), or IO PM 
retinoic acid (4). Cells were cultured in Williams E media containing 
0.2% BSA and I ,uM insulin, but no dexamethasone. For other details, 
see section 2. 
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Fig. 2. Gel chromatography of hcpaiocyteculture medium, containing 50 n&ml IL-6, collected after48 h ofculture. The medium was concentrated 
10 times and 0.2 ml was applied 10 a column (I 2 x 90 cm) packed with Sephadcx G-200,0.75 ml-fractions of the eluale were collected, and analyzed 
for lotal protein by absorbance at 280 nm (open symbols), and a,-m concentrations by rddioimmunoasWy (closed symbols). Tbc elution volumes 
of Blue dextrane, bovine serum albumin, and dinitrophcnyl-alanine are marked with V,, BSA, and V,, rcspcctively. 
The a,-m released from the hepatocytes was finally 
analyzed by SDS-PAGE and immunoblotting of the 
media. Figure 3 shows the result of control hepatocyte 
cultures, or cultures with either IL-6 alone, dcxame- 
thasone alone, or both IL-6 and dexamethasone. Only 
one protein band, with a molecular mass of 28 kDa, was 
bound by anti-a,-m antibodies in the immunoblotting, 
demonstrating that mainly the un-complexed, free form 
of a,-m is secreted from the hepatocytes. The results 
suggest that the small amounts of high molecular weight 
forms of tz,-m which were displayed by the gel chroma- 
tography (Fig. 2) represent dimers or higher orders of 
al-m aggregates. Moreover, the results confirmed those 
presented in Table I, with an enhanced hepatocyte 
production of ol,-m in the presence of IL-6. 
4. DISCUSSION 
The main finding in this study is that IL-6 and LIF 
increase the release of free a,-m into the medium, and 
that the stimulation is enhanced in the presence of the 
dexamethasone. The results indicate that the expression 
of the a,-mfbikunin gene in hepatocytes i regulated by 
cytokines and glucocorticoid hormones, and strongly 
suggests hat an increased synthesis of a,-m and bikunin 
is part of the accute phase response of the liver. The 
findings are in agreement with the demonstration of 
several sequence lements in the a,-m/bikunin gene, in- 
cluding potential glucocorticoid receptor binding sites, 
proposed to be important in the activation of known 
acute phase proteins [6,7]. 
To oi_ir !;now!edge, LA. theeffect of +noic acid on the . A_. . . 
acute phase response has not previously been evaluated. 
We used retinoic acid in the range of concentrations 
from 0. I to 10 ,uM as recommended by other authors 
who studied the induction of hepatic enzymes [24], ex- 
pression of proto-oncogenes in a human embryonal 
cancer cell line [22] or synthesis of heparin-binding 
proteins with growth and neurotrophic activities [23]. 
Retinoic acid enhanced the synthesis of CPI, a,-inhibi- 
tor 3 and a,-m, but had no effect on the synthesis of 
ar,-macrogIobulin a d albumin, suggesting that the re- 
A 
46 - 
1234 1234 
Fig. 3. SDS-PAGE and immunoblotting of hepatoeyte culture media. 
0.1~1 of concentrated control medium (lane I), medium with 50 ngml 
IL-6 (lane 3). medium with 1 PM dcxamctbasone (lane 3), or medium 
with 50 @ml IL-6 and 1 PM dexamcthasone (lane 4), were applied 
to SDS-PAGE (T = 8.5%). slained with Coomussic brilliant blue 
(pnnel A), or transferred to nitrocelluiose membranes and incubattd 
overnight first with rabbit anti-rat q-m, diluted 500 times, and then 
with 1251-labclled goat anti-rabbit immunoglobulins. I@ cpm/ml, 
(panel B). The molecular masses of standard proteins am given in kDa. 
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gulatory role of this molecule is different from the acute 
phase response. Retinoic acid is thought to be involved 
in the development and differentiation of various cell- 
types, acting through specific receptors that belong to 
the steroid/thyroid receptor gene superfamily [33,34]. 
Consequently, retinoic acid is a possible candidate for 
the regulation of the liver expression of al-m, which, 
together with the plasma concentrations, was reported 
to fluctuate during development and ageing of humans 
and rats [ 13,20,2 I], although the physiological function 
of this fluctuation is not known. The effect of retinoic 
acid on al-m synthesis is also interesting due to the fact 
that proteins belonging to the lipocalin superfamily 
have a hydrophobic pocket able to bind several prosthe- 
tic groups, including derivatives of vitamin A [35]. How- 
ever, further studies are required to elucidate the reason 
for the regulation of the synthesis of ol,-m. 
The results indicate that the hepatocytes secrete only 
free a,-m. No trace was found in the hepatocyte 
medium of the complex between al-m and al-inhibitor 
3, reported to be present in the blood of rats [12], indi- 
cating that hepatocytes contribute very little to the 
formation of the complex. Instead, this complex seems 
to be formed outside the hepatocyte. Further studies of 
the mechanisms of the formation of this complex are 
needed to explain the apparent discrepancies that the 
synthesis rate of al-m is increased, whereas the synthesis 
rate of x,-inhibitor 3 is decreased under the influence of 
IL-6 and LIF (Table I). Furthermore, the almost con- 
stant plasma levels of q-m during inflammation, in 
spite of an increased release of the protein from hepa- 
tocytes, as suggested by the results of this work, needs 
to be explained. 
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